Table 1

Baseline characteristics of study population

eTAVI
n=23		eBAV
n=118		Elective TAVI after eBAV
n=32
Age76.0±11.481.3±7.681.2±6.2
Male82.6%
19/23		55.9%
66/118		46.9%
15/32
Logistic Euroscore %37.7±18.135.3±20.825.9±13.9
Coronary artery disease65.2%
15/23		64.3%
74/115		59.4%
19/32
One-vessel disease21.7%
5/23		12.2%
14/115		12.5%
4/32
Two-vessel disease17.4%
4/23		20.9%
24/115		21.9%
7/32
Three-vessel disease26.1%
6/23		31.3%
36/115		25.0%
8/32
PCI in the last 30 days13.0%
3/23		21.7%
25/115		12.5%
4/32
Previous PCI (>30 days)17.4%
4/23		16.5%
19/115		21.9%
7/32
Previous CABG8.7%
2/23		13.0%
15/115		6.3%
2/32
Previous MI17.4%
4/23		42.2%
49/115		37.5%
12/32
Atrial fibrillation30.4%
7/23		61.4%
54/88		46.9%
15/32
Peripheral artery disease Fontaine ≥II17.4%
4/23		19.3%
17/88		9.4%
3/32
Pacemaker before intervention4.3%
1/23		15.2%
16/105		13.8%
4/29
Active malignancy8.7%
2/23		25.3%
20/79		6.7%
2/30
Chronic pulmonary disease21.7%
5/23		16.4%
9/55		6.5%
2/31

  • eBAV, emergency balloon valvuloplasty; eTAVI, emergency transcatheter aortic valve implantation; TAVI, transcatheter aortic valve implantation.